Japan Biopharma Venture Has Surged Almost 400% on Vaccine Hopes

skyline tokyo

Skyline of Tokyo. The Muslim Times has the best collection of articles for the war against Covid 19, especially the vaccines.

Source: Bloomberg

  • AnGes has risen on development of DNA vaccine for coronavirus
  • It’s now the top-weighted stock on Tokyo’s Mothers Index

A Japanese biopharma venture has surged almost 400% in just over two months on hopes that its vaccine candidate for the coronavirus will be successful.

AnGes Inc., a spin-off from Osaka University, announced March 5 that it was developing a DNA vaccine for coronavirus. Thanks to a steady stream of subsequent announcements and tie-up partners and a 25% gain on Thursday, the stock now commands the highest weighting of almost 10% on the 5.88 trillion yen ($55 billion) Tokyo Stock Exchange Mothers startup board.

The pace of the vaccine’s development has attracted significant attention in Japan, with the initial announcement followed in just weeks by the start of pre-clinical trials on animals. Human trials are set to to begin as early as July, with a larger trial of 1,000 people eyed for September, according to reports.

“It’s hard to say anything before the trials begin, but the start line has moved a lot closer,” said ACE Research Institute analyst Tomohiko Ikeno. He noted the speed at which development of the vaccine was progressing, and said tie-ups with other firms and AnGes’ solid balance sheet should allow it to pursue the development.

“The company is working in a field it’s familiar with. It’s not as if they’re in unknown territory.”

DNA vaccines are a novel type of vaccine using genetic material from viruses or bacteria to induce an immune system response. The World Health Organization notes that DNA vaccines have a number of potential advantages over traditional vaccines, including “improved vaccine stability, the absence of any infectious agent and the relative ease of large-scale manufacture.”

But such vaccines have yet to be used in humans — and AnGes’ is just one of 100 potential candidates in pre-clinical trials.

“The problem with vaccines is that you’re putting it into healthy people, and possibly causing more harm than good,” said Bloomberg Intelligence analyst Caroline Stewart.

Read further

The best of the Muslim Times’ collection for war against Covid 19:

In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.

Prime Minister Shinzo Abe says more than 30 countries have asked Japan for favipiravir (Avigan) to fight Covid 19

For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology

Kaiser Permanente launches first coronavirus vaccine trial

Corona Fear’s Cure: Chanting from the Bible and the Quran

Can You Chant from the Bible or the Quran to Bliss and Happiness?

Japanese flu drug ‘clearly effective’ in treating coronavirus, says China

Synthetic antibodies might offer a quick coronavirus treatment

The Four Possible Timelines for Life Returning to Normal

The Muslim Times Recommending Universal BCG Vaccination to Fight the Pandemic

Coronavirus: TB Vaccination Trial Started in Melbourne, Australia

The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources

All of humanity are intimate neighbors: Coronavirus proves it once again

Praise be to God for the Miracle of Our Immune System

USA: 15-minute coronavirus test is here

Does the Ordinary Soap Kill Coronavirus?

Here’s a list of disinfectants you can use against coronavirus

For the number of cases and epidemiology in each country go to: WorldOMeters

Categories: The Muslim Times, Vaccine

1 reply

  1. Woow, this is a good news from Japan, million million people around the world are hoping the covid 19 vaccine.
    Hopefully God will guide Japanes company to produce soon
    Let us all pray to God. Ok,TMT readers

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.